$ARNI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arno Therapeutics, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Arno Therapeutics, Inc. Get notifications about new insider transactions in Arno Therapeutics, Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 09 2013 | ARNI | Arno Therapeutics, ... | WEXFORD CAPITAL LP | Sell | S | 0.48 | 325 | 156 | 2,827,844 | 2.8 M to 2.8 M (-0.01 %) | |
| Jun 04 2013 | ARNI | Arno Therapeutics, ... | Ruchefsky Steven B | Director | Buy | J | 0.30 | 80,556 | 24,167 | 2,493,331 | 2.4 M to 2.5 M (+3.34 %) |
| Jun 03 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 12,889 | 3,867 | 39,555 | 26.7 K to 39.6 K (+48.33 %) |
| Jun 03 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 9,667 | 2,900 | 157,286 | 147.6 K to 157.3 K (+6.55 %) |
| Jun 03 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 22,556 | 6,767 | 196,841 | 174.3 K to 196.8 K (+12.94 %) |
| Jun 03 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 19,333 | 5,800 | 59,333 | 40 K to 59.3 K (+48.33 %) |
| Jun 05 2013 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | J | 0.30 | 9,529 | 2,859 | 473,156 | 463.6 K to 473.2 K (+2.06 %) |
| Jun 05 2013 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | J | 0.30 | 24,548 | 7,364 | 1,218,883 | 1.2 M to 1.2 M (+2.06 %) |
| Jun 05 2013 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | J | 0.30 | 32,589 | 9,777 | 1,618,140 | 1.6 M to 1.6 M (+2.06 %) |
| May 23 2013 | ARNI | Arno Therapeutics, ... | THURMAN RANDY H | Director | Buy | P | 0.50 | 2,500 | 1,250 | 10,000 | 7.5 K to 10 K (+33.33 %) |
| May 23 2013 | ARNI | Arno Therapeutics, ... | THURMAN RANDY H | Director | Buy | P | 0.50 | 7,500 | 3,750 | 7,500 | 0 to 7.5 K |
| May 30 2013 | ARNI | Arno Therapeutics, ... | Zukiwski Alexander A | VP & Chief Medical ... | Buy | J | 0.30 | 9,667 | 2,900 | 29,667 | 20 K to 29.7 K (+48.34 %) |
| May 30 2013 | ARNI | Arno Therapeutics, ... | Proniuk Stefan | VP of Product Devel ... | Buy | J | 0.30 | 1,289 | 387 | 3,955 | 2.7 K to 4 K (+48.35 %) |
| May 30 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Buy | J | 0.30 | 3,222 | 967 | 259,888 | 256.7 K to 259.9 K (+1.26 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 13,333 | 4,000 | 26,666 | 13.3 K to 26.7 K (+100.00 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 10,000 | 3,000 | 147,619 | 137.6 K to 147.6 K (+7.27 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 23,333 | 7,000 | 174,285 | 151 K to 174.3 K (+15.46 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 20,000 | 6,000 | 40,000 | 20 K to 40 K (+100.00 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Ruchefsky Steven B | Director | Buy | J | 0.30 | 83,333 | 25,000 | 2,412,775 | 2.3 M to 2.4 M (+3.58 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Buy | J | 0.30 | 3,333 | 1,000 | 256,666 | 253.3 K to 256.7 K (+1.32 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Zukiwski Alexander A | VP & Chief Medical ... | Buy | J | 0.30 | 10,000 | 3,000 | 20,000 | 10 K to 20 K (+100.00 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | J | 0.30 | 16,291 | 4,887 | 463,627 | 447.3 K to 463.6 K (+3.64 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | J | 0.30 | 41,967 | 12,590 | 1,194,335 | 1.2 M to 1.2 M (+3.64 %) |
| May 07 2013 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | J | 0.30 | 55,714 | 16,714 | 1,585,551 | 1.5 M to 1.6 M (+3.64 %) |
| Apr 15 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 13,333 | 4,000 | 13,333 | 0 to 13.3 K |
| Apr 15 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 10,000 | 3,000 | 137,619 | 127.6 K to 137.6 K (+7.84 %) |
| Apr 15 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 23,333 | 7,000 | 150,952 | 127.6 K to 151 K (+18.28 %) |
| Apr 15 2013 | ARNI | Arno Therapeutics, ... | Belldegrun Arie | Director | Buy | J | 0.30 | 20,000 | 6,000 | 20,000 | 0 to 20 K |
| May 06 2013 | ARNI | Arno Therapeutics, ... | Proniuk Stefan | VP of Product Devel ... | Buy | J | 0.30 | 1,333 | 400 | 2,666 | 1.3 K to 2.7 K (+100.00 %) |
| Apr 11 2013 | ARNI | Arno Therapeutics, ... | Zukiwski Alexander A | VP & Chief Medical ... | Buy | J | 0.30 | 10,000 | 3,000 | 10,000 | 0 to 10 K |
| Apr 10 2013 | ARNI | Arno Therapeutics, ... | Proniuk Stefan | VP of Product Devel ... | Buy | J | 0.30 | 1,333 | 400 | 1,333 | 0 to 1.3 K |
| Apr 10 2013 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | J | 0.30 | 9,529 | 2,859 | 447,336 | 437.8 K to 447.3 K (+2.18 %) |
| Apr 10 2013 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | J | 0.30 | 24,548 | 7,364 | 1,152,368 | 1.1 M to 1.2 M (+2.18 %) |
| Apr 10 2013 | ARNI | Arno Therapeutics, ... | Kariv Tomer | Director | Buy | J | 0.30 | 32,589 | 9,777 | 1,529,837 | 1.5 M to 1.5 M (+2.18 %) |
| Apr 09 2013 | ARNI | Arno Therapeutics, ... | Mattes Glenn R. | President & CEO | Buy | J | 0.30 | 3,333 | 1,000 | 253,333 | 250 K to 253.3 K (+1.33 %) |
| Apr 09 2013 | ARNI | Arno Therapeutics, ... | Ruchefsky Steven B | Director | Buy | J | 0.30 | 83,333 | 25,000 | 2,329,442 | 2.2 M to 2.3 M (+3.71 %) |
| Feb 01 2013 | ARNI | Arno Therapeutics, ... | THURMAN RANDY H | Director | Option Exercise | A | 0.30 | 200,000 | 60,000 | 200,000 | |
| Jan 16 2009 | ARNI | Arno Therapeutics, ... | Berlin Roger G | Chief Executive Off ... | Option Exercise | A | 3.00 | 71,667 | 215,001 | 71,667 | |
| Sep 08 2008 | ARNI | Arno Therapeutics, ... | LENZ BRIAN | Chief Financial Off ... | Buy | L | 3.00 | 2,000 | 6,000 | 2,000 | 0 to 2 K |
| Sep 04 2008 | ARNI | Arno Therapeutics, ... | Berlin Roger G | Chief Executive Off ... | Option Exercise | A | 3.00 | 430,000 | 1,290,000 | 430,000 |